15159498|t|Cholesterol and APOE genotype interact to influence Alzheimer disease progression.
15159498|a|In this retrospective analysis of 443 Alzheimer disease (AD) patients from a 30-week tacrine trial, change in Alzheimer's Disease Assessment Scale score from baseline to final value was significantly associated with a total serum cholesterol/APOE genotype interaction. Disease progression in the no-APOE epsilon4 allele/high-cholesterol subgroup was greater than in the normal-cholesterol subgroups with or without epsilon4. Cholesterol levels and APOE genotype may interact to affect AD progression. The results are consistent with preclinical data on cholesterol's effects in AD.
15159498	0	11	Cholesterol	Chemical	MESH:D002784
15159498	16	20	APOE	Gene	348
15159498	52	69	Alzheimer disease	Disease	MESH:D000544
15159498	121	138	Alzheimer disease	Disease	MESH:D000544
15159498	140	142	AD	Disease	MESH:D000544
15159498	144	152	patients	Species	9606
15159498	168	175	tacrine	Chemical	MESH:D013619
15159498	193	212	Alzheimer's Disease	Disease	MESH:D000544
15159498	313	324	cholesterol	Chemical	MESH:D002784
15159498	325	329	APOE	Gene	348
15159498	382	386	APOE	Gene	348
15159498	408	419	cholesterol	Chemical	MESH:D002784
15159498	460	471	cholesterol	Chemical	MESH:D002784
15159498	508	519	Cholesterol	Chemical	MESH:D002784
15159498	531	535	APOE	Gene	348
15159498	568	570	AD	Disease	MESH:D000544
15159498	636	647	cholesterol	Chemical	MESH:D002784
15159498	661	663	AD	Disease	MESH:D000544
15159498	Association	MESH:D000544	348
15159498	Association	MESH:D002784	348
15159498	Negative_Correlation	MESH:D013619	MESH:D000544
15159498	Association	MESH:D002784	MESH:D000544

